Biotech VC Firm ORI Capital Closes $260M Fund
By Yeji Jesse Lee · February 22, 2024, 6:42 PM EST
Biotech venture capital firm ORI Capital announced Thursday that it has closed a $260 million fund to invest in early-stage biotech companies globally....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login